How Open Science Can Help Researchers Prepare for the Next Pandemic

When the next pandemic arrives, the speed of the global response will depend less on any single breakthrough than on how quickly knowledge can move between laboratories, hospitals and public health agencies. That is the argument at the heart of a growing push for open science — and it is one that the computing industry, including NVIDIA, has begun to embrace as a practical engineering problem rather than an abstract ideal.

The case for opening the pipeline

Open science describes a set of practices that make research outputs available for others to inspect, reuse and build upon. In the life sciences, that can mean publishing genomic sequences as they are collected, releasing protein structure predictions, sharing analysis code in public repositories, or distributing trained machine learning models with documentation of how they were built.

The pandemic-preparedness argument is straightforward. Outbreak response is a race against exponential growth, and duplicated effort is time lost. When a research group anywhere in the world can download a sequence, a dataset or a model weight file and immediately start work, the effective size of the global research workforce expands. Findings can be checked faster, dead ends can be abandoned sooner, and tools built for one pathogen can often be retargeted at another.

Where AI fits

The same logic increasingly applies to artificial intelligence models used in biology. Modern research tools — systems that predict protein structures, design candidate molecules, model how a virus might evolve, or sift through vast volumes of biomedical literature — are expensive to train and require specialized computing infrastructure. Few institutions can build them from scratch.

Releasing such models openly, along with the data recipes and evaluation methods behind them, lowers that barrier. A university lab or a public health agency in a lower-resource setting can fine-tune an existing model for a local pathogen rather than waiting for access to a cluster of accelerators. Open models are also easier to scrutinize: researchers can probe them for failure modes, test them against independent benchmarks and understand where their predictions should not be trusted — an important consideration when results may inform clinical or policy decisions.

GPU-accelerated computing has become central to this work because the underlying problems are enormous. Simulating molecular interactions, screening chemical libraries and analyzing sequencing data at population scale all benefit from parallel hardware. Open software frameworks that make that hardware usable — libraries for genomics, structural biology and drug discovery — are part of the same ecosystem.

Not a free lunch

Openness introduces real trade-offs. Sharing pathogen data raises questions about patient privacy and about equitable benefit for the countries where samples originate. Powerful biological design tools carry dual-use risks that the research community continues to debate, and responsible release practices, access controls and safety evaluations are an active area of work. Open source also requires sustained maintenance; a repository that is abandoned after a grant ends helps no one.

Building before the emergency

Perhaps the most important point is timing. Data-sharing agreements, interoperable formats, reproducible pipelines and trained personnel cannot be improvised in the first weeks of an outbreak. They have to exist beforehand, exercised on ordinary science — seasonal influenza surveillance, antimicrobial resistance, routine structural biology — so that they are ready when the stakes rise.

That is the quieter promise of open science for pandemic preparedness: not a dramatic rescue, but infrastructure that is already in place, already tested, and already shared when it is needed most. Read More